HOME >> BIOLOGY >> NEWS
Preeclampsia solutions sought

SEATTLE, April 4 Developing preeclampsia during pregnancy can result in potentially devastating consequences for both mother and baby. It is one of the leading pregnancy-related causes of death and disability for women and their newborns.

"Preeclampsia often strikes suddenly," said James M. Roberts, M.D., professor and vice chairman of research in the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine and director of the Magee-Womens Research Institute. "And the sad truth is that there currently is no really effective treatment."

Dr. Roberts is giving a talk on prenatal care as part of the first International Preeclampsia Summit, "Partnering to Generate Global Awareness for Preeclampsia," April 4-6 in Seattle. The summit is being sponsored by the Preeclampsia Foundation and is funded through a grant from the Bill and Melinda Gates Foundation.

Every six minutes, a woman dies of preeclampsia nine women an hour, according to the Preeclampsia Foundation. The disorder is linked to hypertension and affects more than 6 million women a year worldwide. Symptoms include high blood pressure, protein in the urine and sometimes swelling in the hands and face. The disorder affects some 5 percent of pregnancies.

The International Preeclampsia Summit is bringing leading experts in the field of preeclampsia together with numerous representatives from global health organizations. The meeting's focus is on identifying and prioritizing appropriate ways to intervene and reduce maternal illness and death due to preeclampsia.

"The Magee-Womens Research Institute and the University of Pittsburgh School of Medicine are solid partners in addressing preeclampsia, one of the top five causes of maternal mortality," said Anne Garrett, executive director of the Preeclampsia Foundation. "It is critical for organizations to align in addressing this condition as more than 200 women a day die from
'"/>

Contact: Michele Baum
412-647-3555
University of Pittsburgh Medical Center
4-Apr-2003


Page: 1 2

Related biology news :

1. Preeclampsia linked with higher risk of preterm delivery
2. Preeclampsia linked with higher risk of preterm delivery and later-life vascular disease
3. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
4. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
5. Grant funds research to develop tissue-engineered solutions for heart disease
6. Summit generates possible solutions to exchange of invasive species in Midwest waterways
7. Study may direct solutions for air pollution disease affecting agricultural, industrial workers
8. New solutions needed for extinction prevention and for sustainable management of marine resources
9. Foot-and-Mouth disease: Can research offer solutions? Science feature examines prevention and detection efforts
10. Women who have donated eggs sought for national study
11. Cutting-edge cancer researchers sought for international recognition

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Preeclampsia solutions sought

(Date:6/19/2013)... A decade-long JDRF-funded study led by the Institute ... is providing a deeper understanding of the link ... 1 diabetes (T1D), highlighting the importance of pre-diabetes ... study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... today in The Journal of the American ...
(Date:6/19/2013)... Cornell University study offers further proof that the divergence ... million years ago was profoundly influenced by mutations to ... and off. , The study, published June 9 in ... hypothesis that regulation of genes must play an important ... humans and chimps in the proteins produced by genes. ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
Breaking Biology News(10 mins):New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
(Date:6/19/2013)... Adding to their already extensive supply of ... Dropette® and Heathrow Scientific disposable plastic transfer ... biology, chemistry and any type of liquid handling analysis ... years, Simport has been supplying the science community with ... Simport Dropette®. Simport’s Dropette® is a one-piece plastic ...
(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13
Cached News: